MENU
TRDA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Entrada Therapeutics (TRDA) Ownership - Who owns Entrada Therapeutics?
Profile
Industry
N/A
Address
One Design Center Place
Phone
+1 857 520-9158
Employees
159
Web
https://www.entradatx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
690.4M
P/E Ratio
12.81
Total Cash
449.34M
Projected Growth
N/A
Total Debt
61.31M
Revenue
215.23M
Risk (Beta)
-0.25
Dividend Yield
N/A
Total Cash/Share
12.01
Total Debt/Equity
N/A
Revenue/Share
6.06 USD as % of share price
Fundamentals
TRDA
Capitalization
690M
P/E Ratio
12.81
Risk (Beta)
-0.25
Dividend Yield
N/A
Total Cash
449M
Total Cash/Share
12.01
Total Debt
61.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.06%
Revenue
215M
ROE
N/A
Book Value
422M
P/B Ratio
1.63
Cash Flow
N/A
Earnings
1.5
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
6.59
Current Revenue Per Employee
110564.97
Dividends Per Share - Security
N/A
EBITDA
61.3M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
10.57
Shares Held By Institutions
605M
Shares Outstanding - Current
37.4M
Total Liabilities
132M
Total Volume MTD
N/A
Value
N/A
Gain YTD
22.266
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
One Design Center Place
Phone
+1 857 520-9158
Employees
159
Web
https://www.entradatx.com